semaglutide ban fda semaglutide ban Why maker of 'magic' weight-loss drug semaglutide wants copies banned

Revising our earlier interpretation of SELECT trial data in light of new analyses. To receive content like this directly in your inbox, click the link in my bio and select Sign Up does glp 1 affect libido GLP 1 receptor agonists may dampen libido, likely through brain pathways Back in 2023 we saw truly unprecedented data for a new drug called ' Retatrutide', which binds to and activates 3 receptors: the GLP1 receptor (like Semaglutide), the GIP receptor (like Early trial data for retatrutide demonstrates exceptional weight loss results, reaching approximately 21% placebo adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under CVS Caremark is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE